Femasys Inc. (NASDAQ:FEMY) Short Interest Up 106.2% in February

Femasys Inc. (NASDAQ:FEMY) was the recipient of a significant increase in short interest in February. As of February 15th, there was short interest totalling 298,300 shares, an increase of 106.2% from the January 31st total of 144,700 shares. Approximately 1.4% of the company’s stock are short sold. Based on an average trading volume of 275,300 shares, the days-to-cover ratio is presently 1.1 days.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on FEMY shares. HC Wainwright reiterated a “buy” rating and set a $12.00 target price on shares of Femasys in a research report on Wednesday. Chardan Capital cut their price objective on Femasys from $10.00 to $8.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th.

Femasys Trading Down 1.3 %

NASDAQ FEMY traded down $0.02 during trading hours on Friday, hitting $1.57. 145,280 shares of the company’s stock were exchanged, compared to its average volume of 273,881. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.26 and a current ratio of 3.94. Femasys has a 12-month low of $0.86 and a 12-month high of $2.40. The firm has a market capitalization of $35.95 million, a P/E ratio of -1.94 and a beta of -2.81. The business’s 50 day moving average is $1.24 and its 200-day moving average is $1.17.

Institutional Investors Weigh In On Femasys

A number of hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in Femasys by 4.7% during the 4th quarter. Geode Capital Management LLC now owns 216,164 shares of the company’s stock valued at $238,000 after purchasing an additional 9,681 shares in the last quarter. Northern Trust Corp grew its stake in Femasys by 42.6% during the 4th quarter. Northern Trust Corp now owns 126,096 shares of the company’s stock valued at $139,000 after purchasing an additional 37,675 shares in the last quarter. Citadel Advisors LLC acquired a new stake in Femasys during the 4th quarter valued at approximately $45,000. XTX Topco Ltd grew its stake in Femasys by 123.9% during the 3rd quarter. XTX Topco Ltd now owns 32,535 shares of the company’s stock valued at $36,000 after purchasing an additional 18,004 shares in the last quarter. Finally, Jane Street Group LLC acquired a new stake in Femasys during the 4th quarter valued at approximately $30,000. Institutional investors and hedge funds own 65.27% of the company’s stock.

About Femasys

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.